Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-1889
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism ; day:17 ; month:8 ; year:2016 ; pages:1-8
Science China / Life sciences. Life sciences ; (17.8.2016), 1-8
- Creator
-
Lu, Yong
- Contributor
-
Lin, Hua
Zhai, Kan
Wang, Xiaojuan
Zhou, Qiong
Shi, Huanzhong
SpringerLink (Online service)
- DOI
-
10.1007/s11427-016-0097-y
- URN
-
urn:nbn:de:1111-201609146298
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lu, Yong
- Lin, Hua
- Zhai, Kan
- Wang, Xiaojuan
- Zhou, Qiong
- Shi, Huanzhong
- SpringerLink (Online service)
Other Objects (12)
Macrophage derived interleukin-10 promotes malignant pleural effusion formation
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
Malignant pleural effusion diagnosis and therapy
Malignant pleural effusion: current understanding and therapeutic approach
mRNA markers associated with malignant pleural effusion
Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion
Thoracoscopic tetracycline poudrage for pleurodesis in malignant pleural effusion
Diagnostic value of medical thoracoscopy in malignant pleural effusion
Closed Pleural Biopsy is Still Useful in the Evaluation of Malignant Pleural Effusion
Chemical pleurodesis for malignant pleural effusion: which agent is perfect?
Circulating biomarkers of malignant pleural effusion deriving from extrapulmonary tumours
Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion
Macrophage derived interleukin-10 promotes malignant pleural effusion formation
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
Malignant pleural effusion diagnosis and therapy
Malignant pleural effusion: current understanding and therapeutic approach
mRNA markers associated with malignant pleural effusion
Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion
Thoracoscopic tetracycline poudrage for pleurodesis in malignant pleural effusion
Diagnostic value of medical thoracoscopy in malignant pleural effusion
Closed Pleural Biopsy is Still Useful in the Evaluation of Malignant Pleural Effusion
Chemical pleurodesis for malignant pleural effusion: which agent is perfect?
Circulating biomarkers of malignant pleural effusion deriving from extrapulmonary tumours
Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion
Macrophage derived interleukin-10 promotes malignant pleural effusion formation
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
Malignant pleural effusion diagnosis and therapy
Malignant pleural effusion: current understanding and therapeutic approach
mRNA markers associated with malignant pleural effusion
Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion
Thoracoscopic tetracycline poudrage for pleurodesis in malignant pleural effusion
Diagnostic value of medical thoracoscopy in malignant pleural effusion
Closed Pleural Biopsy is Still Useful in the Evaluation of Malignant Pleural Effusion
Chemical pleurodesis for malignant pleural effusion: which agent is perfect?
Circulating biomarkers of malignant pleural effusion deriving from extrapulmonary tumours